CD19 and gastric cancer: As antigen-presenting cells, B lymphocytes indirectly participate in the cellular immune response, playing an important role in both innate and adaptive immunity.[46,47] Prior studies have shown that gastric cancer patients with high CD19+ B lymphocyte levels in their peripheral blood have longer overall survival.[48] However, the regulatory relationship between PD-L1 and CD19 expression requires further clarification.